Clinical Effectiveness of a Newly Developed Collagen Substitute (InsureGraf®)
Journal of Korean Burn Society
;
: 12-15, 2017.
Artigo
em Coreano
| WPRIM
| ID: wpr-167672
ABSTRACT
PURPOSE:
Aim of this study was to assess effects of InsureGraf® (SK-Bioland Co., Korea), an artificial dermis developed by using tissue engineering technology in severe burn patients.METHODS:
To examine the clinical effectiveness of InsureGraf®, we transplanted them in patients with severe burns. A total of 14 joint regions in 8 patients received InsureGraf® graft selectively from July to December, 2014. The graft results were determined after confirming the take rate of the transplanted skin graft on top of the InsureGraf®. Take rates were examined twice, at 7 and 14 days after grafting. Photographs of the skin grafts were evaluated individually by two burn surgeon specialists, and the mean values were recorded.RESULTS:
The take rate was 99% after day 7 and 100% after day 14 respectively.CONCLUSION:
InsureGraf® can be used successfully as an artificial dermis that allows one-stage operation in severe burn patients, exhibiting a successful early-stage graft take rate that is close to 100%.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Pele
/
Especialização
/
Queimaduras
/
Colágeno
/
Resultado do Tratamento
/
Transplantes
/
Derme
/
Engenharia Tecidual
/
Articulações
Limite:
Humanos
Idioma:
Coreano
Revista:
Journal of Korean Burn Society
Ano de publicação:
2017
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS